Meta-analysis evaluates immune checkpoint inhibitor-based neoadjuvant therapy for proficient mismatch repair and microsatellite stable locally advanced rectal tumors. (Clinical Colorectal Cancer)
Immunotherapy combinations tested in pMMR/MSS rectal cancer
The CRC Digest